244 related articles for article (PubMed ID: 17601391)
1. Contemporary use of clopidogrel in patients with coronary artery disease.
Parikh SA; Beckman JA
Curr Cardiol Rep; 2007 Jul; 9(4):257-63. PubMed ID: 17601391
[TBL] [Abstract][Full Text] [Related]
2. The thienopyridines in coronary artery disease.
Berger PB
Curr Cardiol Rep; 1999 Sep; 1(3):192-8. PubMed ID: 10980841
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting.
Mishkel GJ; Aguirre FV; Ligon RW; Rocha-Singh KJ; Lucore CL
J Am Coll Cardiol; 1999 Dec; 34(7):1884-90. PubMed ID: 10588198
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.
Steinhubl SR; Topol EJ
J Thromb Thrombolysis; 1999 Jun; 7(3):227-31. PubMed ID: 10373712
[No Abstract] [Full Text] [Related]
5. Optimal antiplatelet treatment for percutaneous coronary intervention: clopidogrel vs. ticlopidine.
Almsherqi ZA; McLachlan CS; Mossop P; Deng Y
Int J Cardiol; 2007 Jan; 114(1):101-2. PubMed ID: 16343664
[TBL] [Abstract][Full Text] [Related]
6. [Combination of clopidogrel and aspirin was no better than aspirin alone for prevention of atherothrombotic events in stable patients. Results of CHARISMA].
Granitskiĭ NA
Kardiologiia; 2006; 46(5):73-5. PubMed ID: 16858363
[No Abstract] [Full Text] [Related]
7. Role of clopidogrel in managing atherothrombotic cardiovascular disease.
Eshaghian S; Kaul S; Amin S; Shah PK; Diamond GA
Ann Intern Med; 2007 Mar; 146(6):434-41. PubMed ID: 17371888
[TBL] [Abstract][Full Text] [Related]
8. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
Matetzky S; Shenkman B; Guetta V; Shechter M; Beinart R; Goldenberg I; Novikov I; Pres H; Savion N; Varon D; Hod H
Circulation; 2004 Jun; 109(25):3171-5. PubMed ID: 15184279
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.
Sharma RK; Reddy HK; Singh VN; Sharma R; Voelker DJ; Bhatt G
Vasc Health Risk Manag; 2009; 5():965-72. PubMed ID: 19997577
[TBL] [Abstract][Full Text] [Related]
11. Successful Prasugrel Therapy for Recurrent Left Main Stent Thrombosis in a Clopidogrel Hyporesponder.
Kim YS; Lee SR
Tex Heart Inst J; 2015 Oct; 42(5):483-6. PubMed ID: 26504448
[TBL] [Abstract][Full Text] [Related]
12. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999.
McCullough PA; Marks KR
J Thromb Thrombolysis; 1999 Jun; 7(3):233-9. PubMed ID: 10373716
[No Abstract] [Full Text] [Related]
14. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
16. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
17. Identifying clopidogrel resistance during chronic therapy: the case for a biochemical approach.
Horowitz JD; Chirkov YY
Thromb Haemost; 2008 Oct; 100(4):519-20. PubMed ID: 18841269
[No Abstract] [Full Text] [Related]
18. Coronary artery disease: Platelet activity: an obstacle for successful PCI.
Gawaz M; Geisler T
Nat Rev Cardiol; 2009 Jun; 6(6):391-2. PubMed ID: 19471282
[TBL] [Abstract][Full Text] [Related]
19. A case report of simultaneous thrombosis of two coronary artery stents in association with clopidogrel resistance.
Lee JS; Dunn SP; Marshall HM; Cohen MG; Smyth SS
Clin Cardiol; 2007 Apr; 30(4):200-3. PubMed ID: 17443655
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet agents in cardiology: the choice of therapy.
Steinhubl SR
Ann Thorac Surg; 2000 Aug; 70(2 Suppl):S3-8. PubMed ID: 10966004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
